InspireMD, Inc.(NSPR)
Health Care Equipment
Neurostimulation Devices
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership changeShares owned | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | Stuka Paul Director | Purchase | +20,000 | +1.38%1,465,158 | $0.88 | $17,500 | View SEC filing | |
| 2026-05-21 | Gleason Shane Thomas Chief Commercial Officer | Sale | -85,295 | -7.49%1,053,882 | $2.22 | $189,594 | View SEC filing | |
| 2026-05-15 | Stuka Paul Director | Purchase | +15,000 | +1.05%1,445,158 | $1.16 | $17,325 | View SEC filing | |
| 2026-05-13 | Slosman Marvin CEO and President | Purchase | +21,000 | +0.82%2,577,760 | $1.20 | $25,200 | View SEC filing | |
| 2026-05-13 | Stuka Paul Director | Purchase | +75,626 | +5.58%1,430,158 | $1.16 | $88,026 | View SEC filing | |
| 2026-05-12 | Stuka Paul Director | Purchase | +75,626 | +5.91%1,354,532 | $1.16 | $88,026 | View SEC filing | |
| 2026-05-08 | Ward Scott R. Director | Purchase | +89,250 | +51.92%261,161 | $1.15 | $102,638 | View SEC filing | |
| 2026-05-08 | Stuka Paul Director | Purchase | +7,895 | +0.62%1,278,906 | $1.14 | $9,034 | View SEC filing | |
| 2026-05-08 | ROUBIN GARY S Director | Purchase | +90,000 | +10.03%987,470 | $1.18 | $106,200 | View SEC filing | |
| 2026-02-23 | Stuka Paul Director | Purchase | +2,710 | +0.70%391,628 | $1.81 | $4,905 | View SEC filing | |
| 2026-02-02 | Gleason Shane Thomas Chief Commercial Officer | Sale | -61,194 | -5.10%1,139,177 | $1.62 | $99,331 | View SEC filing | |
| 2025-12-11 | Stuka Paul Director | Purchase | +5,073 | +0.61%835,823 | $1.81 | $9,182 | View SEC filing | |
| 2025-12-08 | Stuka Paul Director | Purchase | +5,073 | +0.61%833,113 | $1.86 | $9,436 | View SEC filing | |
| 2025-12-05 | Stuka Paul Director | Purchase | +10,130 | +1.24%828,040 | $1.85 | $18,741 | View SEC filing | |
| 2025-11-13 | Stuka Paul Director | Purchase | +13,431 | +1.67%817,910 | $1.62 | $21,758 | View SEC filing | |
| 2025-08-01 | ROUBIN GARY S Director | Purchase | +41,322 | +7.29%608,425 | $2.42 | $99,999 | View SEC filing | |
| 2025-08-01 | Kester Thomas J Director | Purchase | +30,991 | +7.95%420,758 | $2.42 | $74,998 | View SEC filing | |
| 2025-08-01 | Slosman Marvin CEO and President | Purchase | +10,330 | +0.43%2,420,866 | $2.42 | $24,999 | View SEC filing | |
| 2025-08-01 | Stuka Paul Director | Purchase | +20,661 | +2.64%804,479 | $2.42 | $50,000 | View SEC filing | |
| 2023-12-04 | ROUBIN GARY S Director | Purchase | +50,000 | +12.86%438,902 | $2.53 | $126,540 | View SEC filing | |
| 2023-05-16 | Stuka Paul Director | Purchase | +525,000 | +713.96%598,534 | $1.63 | $857,168 | View SEC filing | |
| 2023-05-16 | Kester Thomas J Director | Purchase | +183,747 | +388.14%231,088 | $1.63 | $300,004 | View SEC filing | |
| 2023-05-16 | BERMAN MICHAEL Director | Purchase | +367,491 | +100.00%367,491 | $1.63 | $600,003 | View SEC filing | |
| 2023-05-16 | ROUBIN GARY S Director | Purchase | +183,747 | +106.65%356,043 | $1.63 | $300,004 | View SEC filing | |
| 2022-08-22 | ROUBIN GARY S Director | Purchase | +35,500 | +27.58%164,194 | $1.91 | $67,770 | View SEC filing |
1-25 of 79